Literature DB >> 24452563

Methotrexate and trimethoprim-sulfamethoxazole: toxicity from this combination continues to occur.

Jessica Cudmore1, Matthew Seftel, Jeffrey Sisler, Ryan Zarychanski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24452563      PMCID： PMC3994806     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  12 in total

1.  Interaction between trimethoprim-sulfamethoxazole and methotrexate in children with leukemia.

Authors:  G Ferrazzini; J Klein; H Sulh; D Chung; E Griesbrecht; G Koren
Journal:  J Pediatr       Date:  1990-11       Impact factor: 4.406

Review 2.  Methotrexate drug interactions in the treatment of rheumatoid arthritis: a systematic review.

Authors:  Josiane Bourré-Tessier; Boulos Haraoui
Journal:  J Rheumatol       Date:  2010-05-01       Impact factor: 4.666

3.  Megaloblastic pancytopenia in a patient receiving concurrent methotrexate and trimethoprim-sulfamethoxazole treatment.

Authors:  M Maricic; M Davis; E P Gall
Journal:  Arthritis Rheum       Date:  1986-01

4.  Pancytopenia induced by the interaction between methotrexate and trimethoprim-sulfamethoxazole.

Authors:  D R Thomas; J S Dover; R D Camp
Journal:  J Am Acad Dermatol       Date:  1987-12       Impact factor: 11.527

5.  [Pancytopenia during treatment of rheumatoid arthritis with methotrexate after administration of trimethoprim-sulfamethoxazole].

Authors:  J P Thevenet; J M Ristori; H Cure; M H Mizony; J L Bussiere
Journal:  Presse Med       Date:  1987-09-19       Impact factor: 1.228

Review 6.  Trimethoprim-sulfamethoxazole. Metabolism of folic acid in man.

Authors:  V Herbert
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

7.  Methotrexate and trimethoprim-sulphamethoxazole--a potentially hazardous combination.

Authors:  H Groenendal; F H Rampen
Journal:  Clin Exp Dermatol       Date:  1990-09       Impact factor: 3.470

Review 8.  Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis.

Authors:  B Bannwarth; F Péhourcq; T Schaeverbeke; J Dehais
Journal:  Clin Pharmacokinet       Date:  1996-03       Impact factor: 6.447

9.  Methotrexate toxicity in a patient receiving trimethoprim-sulfamethoxazole.

Authors:  M H Thomas; L A Gutterman
Journal:  J Rheumatol       Date:  1986-04       Impact factor: 4.666

Review 10.  Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research.

Authors:  C Salliot; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2008-12-05       Impact factor: 19.103
View more
  4 in total

1.  Synergistic Effects of BTK Inhibitor HM71224 and Methotrexate in a Collagen-induced Arthritis Rat Model.

Authors:  Kyung Jin Choi; Yu-Yon Kim; Sun Young Jang; Young Gil Ahn; Kwee Hyun Suh; Young Hoon Kim; Hyung Sik Kim
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

2.  Incomplete Stevens-Johnson Syndrome Caused by Sulfonamide Antimicrobial Exposure.

Authors:  Nikki B Canter; Lane M Smith
Journal:  Clin Pract Cases Emerg Med       Date:  2019-05-29

Review 3.  Management of Inflammatory Bowel Disease in the Elderly.

Authors:  Elizabeth S John; Kristina Katz; Mark Saxena; Sita Chokhavatia; Seymour Katz
Journal:  Curr Treat Options Gastroenterol       Date:  2016-09

4.  Accidental Chronic Poisoning with Methotrexate; Report of Two Cases.

Authors:  Reza Bidaki; Mojgan Kian; Hamid Owliaey; Mojtaba Babaei Zarch; Masoud Feysal
Journal:  Emerg (Tehran)       Date:  2017-05-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.